These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15178713)

  • 21. Low-molecular-weight heparins and glycoprotein IIb/IIIa inhibitors with percutaneous coronary intervention in acute coronary syndromes.
    Shimpi RA
    J Invasive Cardiol; 2003 Aug; 15(8):460-5. PubMed ID: 12890880
    [No Abstract]   [Full Text] [Related]  

  • 22. Antithrombotic therapy in peripheral arterial occlusive disease.
    Jackson MR; Clagett GP
    Chest; 2001 Jan; 119(1 Suppl):283S-299S. PubMed ID: 11157655
    [No Abstract]   [Full Text] [Related]  

  • 23. Antithrombotic therapy in peripheral arterial occlusive disease.
    Clagett GP; Graor RA; Salzman EW
    Chest; 1992 Oct; 102(4 Suppl):516S-528S. PubMed ID: 1395832
    [No Abstract]   [Full Text] [Related]  

  • 24. Animal models for arterial thrombolysis and prevention of reocclusion. Erythrocyte-rich versus platelet-rich thrombus.
    Gold HK; Yasuda T; Jang IK; Guerrero JL; Fallon JT; Leinbach RC; Collen D
    Circulation; 1991 Jun; 83(6 Suppl):IV26-40. PubMed ID: 2040069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolonged inhibition of acute arterial thrombosis by high dosing of a monoclonal anti-platelet glycoprotein IIb/IIIa antibody in a baboon model.
    Kotzé HF; Badenhorst PN; Lamprecht S; Meiring M; Van Wyk V; Nuyts K; Stassen JM; Vermylen J; Deckmyn H
    Thromb Haemost; 1995 Aug; 74(2):751-7. PubMed ID: 8585017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subacute stent thrombosis successfully treated with thrombolysis and glycoprotein IIb/IIIa inhibition.
    Bowater SE; Doshi SN; Buller NP
    Heart; 2005 Apr; 91(4):488. PubMed ID: 15772208
    [No Abstract]   [Full Text] [Related]  

  • 27. [Use of antithrombotic drugs in the treatment of peripheral occlusive arterial diseases].
    Violi F
    Minerva Cardioangiol; 1999 Nov; 47(11):416. PubMed ID: 10681239
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of acute basilar artery thrombosis with a combination of systemic alteplase and tirofiban, a nonpeptide platelet glycoprotein IIb/IIIa inhibitor: report of four cases.
    Junghans U; Seitz RJ; Wittsack HJ; Aulich A; Siebler M
    Radiology; 2001 Dec; 221(3):795-801. PubMed ID: 11719681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utilization of GP IIb/IIIa inhibitors in peripheral percutaneous interventions: current applications and in-hospital outcomes at a tertiary referral center.
    Shammas NW; Dippel EJ; Shammas GA; Kumar A; Jerin M; Kennedy L
    J Invasive Cardiol; 2008 Jun; 20(6):266-9. PubMed ID: 18523317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiplatelet effect of FK633, a platelet glycoprotein IIb/IIIa antagonist, on thrombus formation and vascular patency after thrombolysis in the injured hamster carotid artery.
    Kaida T; Matsuno H; Niwa M; Kozawa O; Miyata H; Uematsu T
    Thromb Haemost; 1997 Mar; 77(3):562-7. PubMed ID: 9066011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Systemic and regional fibrinolytic treatment of peripheral arterial occlusions: proven indications?].
    Kröger K
    Hamostaseologie; 2006 Aug; 26(3):214-9. PubMed ID: 16906238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet GPIIb/IIIa receptor blockers for failed thrombolysis in acute myocardial infarction, alone or as adjunct to other rescue therapies.
    Mahadevan VS; McCarty D; Adgey AA
    Eur Heart J; 2002 Oct; 23(19):1490-1. PubMed ID: 12242068
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of peripheral arterial diseases].
    Mikita J
    Orv Hetil; 2005 May; 146(22):1209-11. PubMed ID: 15997667
    [No Abstract]   [Full Text] [Related]  

  • 34. Initial experience with the combination of reteplase and abciximab for thrombolytic therapy in peripheral arterial occlusive disease: a pilot study.
    Drescher P; Crain MR; Rilling WS
    J Vasc Interv Radiol; 2002 Jan; 13(1):37-43. PubMed ID: 11788692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of surgical and thrombolytic treatment of peripheral arterial disease.
    Ouriel K
    Rev Cardiovasc Med; 2002; 3 Suppl 2():S7-16. PubMed ID: 12556738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TP 9201.
    Drugs R D; 1999 May; 1(5):390-1. PubMed ID: 10566073
    [No Abstract]   [Full Text] [Related]  

  • 37. Glycoprotein IIb/IIIa inhibitors and no-reflow.
    Kloner RA; Dai W
    J Am Coll Cardiol; 2004 Jan; 43(2):284-6. PubMed ID: 14736450
    [No Abstract]   [Full Text] [Related]  

  • 38. Peripheral arterial disease: drug therapy.
    Schwartz JB
    J Gend Specif Med; 2002; 5(4):16-20. PubMed ID: 12192882
    [No Abstract]   [Full Text] [Related]  

  • 39. Platelet GP IIb/IIIa receptor blockers for failed thrombolysis in acute myocardial infarction, alone or as adjunct to other rescue therapies; single centre retrospective analysis of 548 consecutive patients with acute myocardial infarction.
    Ronner E; van Domburg RT; van den Brand MJ; de Feyter PJ; Foley DP; van der Giessen WJ; Serruys PW; Simoons ML
    Eur Heart J; 2002 Oct; 23(19):1529-37. PubMed ID: 12242073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Combination therapy for acute myocardial infarction with glycoprotein IIb/IIIa inhibitors and fibrinolysis].
    Ottani F; Bresciani B; La Vecchia L; Favero L; Fontanelli A; Galvani M
    Ital Heart J Suppl; 2002 May; 3(5):544-54. PubMed ID: 12064194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.